We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$83B
AUM Growth
+$4.08B
(+5.2%)
Cap. Flow
-$2.07B
Cap. Flow
% of AUM
-2.5%
Top 10 Holdings %
Top 10 Hldgs %
13.18%
Holding
730
New
59
Increased
161
Reduced
398
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$550M |
| 2 |
Fidelity National Information Services
FIS
|
+$353M |
| 3 |
Global Payments
GPN
|
+$263M |
| 4 |
CVS Health
CVS
|
+$175M |
| 5 |
Devon Energy
DVN
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$433M |
| 2 |
Lowe's Companies
LOW
|
+$277M |
| 3 |
Oracle
ORCL
|
+$226M |
| 4 |
Progressive
PGR
|
+$220M |
| 5 |
Las Vegas Sands
LVS
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.96% |
| 2 | Healthcare | 15.3% |
| 3 | Industrials | 15.12% |
| 4 | Technology | 14.91% |
| 5 | Consumer Discretionary | 11.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MCHB
476
Mechanics Bancorp
MCHB
$3.56B
| $1.63M | ﹤0.01% |
31,248
-28,471
| -48% | -$1.37M |
|
477
Designer Brands
DBI
$313M
| $1.6M | ﹤0.01% |
112,348
+28,989
| +35% | +$415K |
|
478
KB Financial Group
KB
$39.6B
| $1.58M | ﹤0.01% |
34,137
+767
| +2% | +$36.4K |
|
479
Fabrinet
FN
$14.5B
| $1.54M | ﹤0.01% |
12,964
-4,485
| -26% | -$497K |
|
480
Western Alliance Bancorporation
WAL
$8.89B
| $1.51M | ﹤0.01% |
14,002
| – | – |
|
481
BGC Group
BGC
$5.69B
| $1.5M | ﹤0.01% |
323,662
| – | – |
|
482
FirstCash
FCFS
$8.79B
| $1.48M | ﹤0.01% |
19,761
+12,031
| +156% | +$925K |
|
483
UFP Industries
UFPI
$4.98B
| $1.43M | ﹤0.01% |
15,544
| – | – |
|
484
Morgan Stanley
MS
$321B
| $1.43M | ﹤0.01% |
14,558
-2,367
| -14% | -$236K |
|
485
IQVIA
IQV
$40.5B
| $1.43M | ﹤0.01% |
5,059
-512
| -9% | -$133K |
|
486
AerCap
AER
$23.7B
| $1.41M | ﹤0.01% |
21,611
-18,018
| -45% | -$1.12M |
|
487
Kroger
KR
$36.9B
| $1.4M | ﹤0.01% |
30,969
+23,300
| +304% | +$980K |
|
|
SCU
488
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $1.4M | ﹤0.01% |
65,551
+37,768
| +136% | +$862K |
|
489
Knight Transportation
KNX
$11.3B
| $1.38M | ﹤0.01% |
22,556
-4,840
| -18% | -$274K |
|
490
Hackett Group
HCKT
$275M
| $1.35M | ﹤0.01% |
65,854
| – | – |
|
491
Kirby Corp
KEX
$7.14B
| $1.35M | ﹤0.01% |
+22,740
| New | +$1.27M |
|
|
ATSG
492
DELISTED
Air Transport Services Group
ATSG
| $1.34M | ﹤0.01% |
45,796
-2,198
| -5% | -$58.5K |
|
493
Peoples Bancorp
PEBO
$1.51B
| $1.34M | ﹤0.01% |
42,231
-22,054
| -34% | -$709K |
|
494
Bank OZK
OZK
$5.61B
| $1.34M | ﹤0.01% |
28,810
-3,371
| -10% | -$154K |
|
|
SJI
495
DELISTED
South Jersey Industries, Inc.
SJI
| $1.34M | ﹤0.01% |
51,150
-6,419
| -11% | -$153K |
|
496
Ericsson
ERIC
$32.4B
| $1.32M | ﹤0.01% |
121,500
+21,857
| +22% | +$239K |
|
497
Lockheed Martin
LMT
$132B
| $1.32M | ﹤0.01% |
3,704
+465
| +14% | +$161K |
|
498
The RMR Group
RMR
$335M
| $1.31M | ﹤0.01% |
37,912
+11,672
| +44% | +$404K |
|
499
Tiptree Inc
TIPT
$693M
| $1.31M | ﹤0.01% |
94,990
-50,546
| -35% | -$708K |
|
|
PINE
500
Alpine Income Property Trust
PINE
$340M
| $1.31M | ﹤0.01% |
65,401
| – | – |
|
Similar funds
Boston Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Boston Partners held 730 positions worth $83B, up 5.2% from $78.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Boston Partners's Q4 2021 filing shows 59 new, 161 increased, 398 reduced and 45 closed positions. Its largest new stake was Keurig Dr Pepper: 15,605,496 shares worth $575M. The largest sale was Pfizer, an estimated $433M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q4 2021 buy was Keurig Dr Pepper: 15,605,496 shares worth $575M.
- Boston Partners added most to Fidelity National Information Services in Q4 2021, an estimated $353M increase.
- Boston Partners's biggest Q4 2021 reduction was Pfizer, cutting an estimated $433M.
- Boston Partners fully exited CyrusOne Inc Common Stock in Q4 2021, selling an estimated $137M.
- Boston Partners's ten largest holdings make up 13% of its $83B portfolio in Q4 2021.
- Boston Partners opened 59 new positions and closed 45 in Q4 2021.
- Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $83B.
Based on Boston Partners's 13F filing for Q4 2021, filed 4 Feb 2022.